Dabur India Limited
Quality (64/100) does the heavy lifting; valuation (8/100) is the drag.
ExpensiveOvervaluedOur blended model reads Dabur India Limited as a Sell at 36/100. On 39.8x trailing earnings it sits pricier than the Consumer Defensive median of about 26.1x. The price is about 26% below its 52-week high of ₹518.62 and 4% above the low of ₹371.55. Financial health scores 100/100, in the safe band on the Altman Z-score, with a Piotroski F-score of 5/9. The average analyst target of ₹525.62 implies about 36% upside across 37 analysts. It clears 7 of 14 investability checks, with durability 64, valuation 16 and momentum 16 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹175.56.
Analyst views
1-year price
EOD · 2026-09-2552-week range
-25.65% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Sell36Piotroski F-score 5/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Pass: ROE above 15%: 16.2%
- Pass: Low debt (D/E < 0.5): 0.11x
- Pass: Positive free cash flow
- Fail: Revenue growth > 10%: 7%
- Pass: Earnings growing: 15%
- Pass: Net margin ≥ 10%: 14.4%
- Pass: Current ratio > 1.5: 1.70
- Fail: Below our fair value
- Fail: Margin of safety ≥ 20%
- Fail: Above 200-day average
- Fail: Above 50-day average
- Fail: Positive 1-year return
- Pass: Altman Z in safe zone: Z 9.74
- Fail: Piotroski ≥ 7: 5/9
Quarterly results
Annual financials
Shareholding
- Promoter67.7%
- Institutions23.3%
- Public & other9.1%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Lightly leveraged balance sheet.
- Financially solid — Altman Z 9.74.
Opportunities
- Earnings growing (15% YoY).
Bear case
Weaknesses
- Price below its 200-day moving average (downtrend).
- Down 22% over the past year.
Threats
- Rich valuation versus sector peers.
- Trades ~43% above our estimated fair value.
About Dabur India Limited
Dabur India Limited is a global fast-moving consumer goods company operating through Consumer Care, Foods, Retail, and Other segments. It manufactures health supplements including Dabur Chyawanprash, Dabur Honey, and Dabur Glucose; digestive products such as Hajmola and Pudin Hara; cough and cold remedies under Honitus; rejuvenators including Shilajit; health juices; and nutraceuticals.
Dabur India Limited — frequently asked questions
Is Dabur India Limited a buy, hold or sell?
StocksWizard currently rates Dabur India Limited (DABUR) a Sell, based on a blended score of 36/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Dabur India Limited's fair value?
Our blended DCF and relative-valuation model estimates Dabur India Limited's fair value at about ₹219.45, versus a current price of ₹385.6 — roughly 43% downside. On that basis the stock looks overvalued by 43%.
Is Dabur India Limited financially healthy?
Dabur India Limited scores 100/100 on our financial-health model, placing it in the safe band on the Altman Z-score, with a Piotroski F-score of 5/9.
How has Dabur India Limited's share price performed?
Dabur India Limited is down 22% over the past year and down 7% over three months, and last traded at ₹385.6. Past performance doesn't predict future returns.
More in Consumer Defensive
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.